BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 31637265)

  • 1. Urinary NGAL and RBP Are Biomarkers of Normoalbuminuric Renal Insufficiency in Type 2 Diabetes Mellitus.
    Li A; Yi B; Liu Y; Wang J; Dai Q; Huang Y; Li YC; Zhang H
    J Immunol Res; 2019; 2019():5063089. PubMed ID: 31637265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary RBP and NGAL Levels are Associated with Nephropathy in Patients with Type 2 Diabetes.
    Wu J; Shao X; Lu K; Zhou J; Ren M; Xie X; Liu J; Xu Y; Ding Y; Shen X; Zhu C
    Cell Physiol Biochem; 2017; 42(2):594-602. PubMed ID: 28954270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The changes of serum sKlotho and NGAL levels and their correlation in type 2 diabetes mellitus patients with different stages of urinary albumin.
    Wu C; Wang Q; Lv C; Qin N; Lei S; Yuan Q; Wang G
    Diabetes Res Clin Pract; 2014 Nov; 106(2):343-50. PubMed ID: 25263500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlations of Serum Retinol-Binding Protein and Stromal Cell-Derived Factor-1 with Renal Function in Patients with Diabetic Kidney Disease.
    Huang J; Liu J; Liu W
    Clin Lab; 2024 Jan; 70(1):. PubMed ID: 38213220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil Gelatinase-Associated Lipocalin and Retinol-Binding Protein-4 as Biomarkers for Diabetic Kidney Disease.
    Abbasi F; Moosaie F; Khaloo P; Dehghani Firouzabadi F; Fatemi Abhari SM; Atainia B; Ardeshir M; Nakhjavani M; Esteghamati A
    Kidney Blood Press Res; 2020; 45(2):222-232. PubMed ID: 32008005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary tubular biomarkers in short-term type 2 diabetes mellitus patients: a cross-sectional study.
    Fu WJ; Xiong SL; Fang YG; Wen S; Chen ML; Deng RT; Zheng L; Wang SB; Pen LF; Wang Q
    Endocrine; 2012 Feb; 41(1):82-8. PubMed ID: 21779943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of urinary neutrophil gelatinase-associated lipocalin, clusterin, and cystatin C in predicting diabetic kidney disease and diabetic microalbuminuria: a consecutive cohort study.
    Zeng XF; Lu DX; Li JM; Tan Y; Li Z; Zhou L; Xi ZQ; Zhang SM; Duan W
    BMC Nephrol; 2017 Jul; 18(1):233. PubMed ID: 28701152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significant association of urinary alpha-1-microglobulin compared to urinary neutrophil gelatinase-associated lipocalin with renal insufficiency in patients with type 2 diabetes.
    Chen G; Shan X; Wang H
    Nephrology (Carlton); 2021 May; 26(5):400-407. PubMed ID: 33484208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as indicators of tubular damage in normoalbuminuric patients with type 2 diabetes.
    de Carvalho JA; Tatsch E; Hausen BS; Bollick YS; Moretto MB; Duarte T; Duarte MM; Londero SW; Premaor MO; Comim FV; Delanghe JR; Moresco RN
    Clin Biochem; 2016 Feb; 49(3):232-6. PubMed ID: 26519090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of urinary non-albumin protein with the different urinary marker for glomerular and tubular damage in patients with type 2 diabetes.
    Siddiqui K; Joy SS; Nawaz SS; Alnaqeb D; Mujammami M; Al-Rubeaan K
    BMC Nephrol; 2020 Jul; 21(1):255. PubMed ID: 32631266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of neutrophil gelatinase-associated lipocalin and cystatin C as early markers of diabetic nephropathy.
    Siddiqi Z; Karoli R; Kaul A; Fatima J; Varshney S; Beg MS
    Ann Afr Med; 2017; 16(3):101-106. PubMed ID: 28671149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of urinary NGAL for differential diagnosis and progression of diabetic kidney disease.
    Duan S; Chen J; Wu L; Nie G; Sun L; Zhang C; Huang Z; Xing C; Zhang B; Yuan Y
    J Diabetes Complications; 2020 Oct; 34(10):107665. PubMed ID: 32653382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Markers of Glomerular and Tubular Damage in the Early Stage of Kidney Disease in Type 2 Diabetic Patients.
    Żyłka A; Dumnicka P; Kuśnierz-Cabala B; Gala-Błądzińska A; Ceranowicz P; Kucharz J; Ząbek-Adamska A; Maziarz B; Drożdż R; Kuźniewski M
    Mediators Inflamm; 2018; 2018():7659243. PubMed ID: 30158836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Urinary retinol binding protein and β
    Li SM; Wang YA; Liu W; Wu ZY; Chen L; Cai XL; Zhang R; Yang WJ; Liu Y; Ma YM; Gong SQ; Zhang SM; Ren Q; Han XY; Ji LN
    Zhonghua Nei Ke Za Zhi; 2021 May; 60(5):438-445. PubMed ID: 33906273
    [No Abstract]   [Full Text] [Related]  

  • 15. Nonalbuminuric proteinuria as a biomarker for tubular damage in early development of nephropathy with type 2 diabetic patients.
    Kim SS; Song SH; Kim IJ; Kim WJ; Jeon YK; Kim BH; Kwak IS; Lee EK; Kim YK
    Diabetes Metab Res Rev; 2014 Nov; 30(8):736-41. PubMed ID: 24687388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative diagnostic utility of different urinary biomarkers during pre-albuminuric stages of non-hypertensive type 2 diabetic nephropathy.
    Mahapatra HS; Kulshreshtha B; Goyal P; Chitkara A; Kumari A; Arora A; Sekhar V; Gupta YP
    Indian J Med Res; 2022 Jul; 156(1):46-55. PubMed ID: 36510897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study on the status of normoalbuminuric renal insufficiency among type 2 diabetes mellitus patients: A multicenter study based on a Chinese population.
    Jia X; Zang L; Pang P; Jiang L; Du J; Gu W; Ba J; Mu Y; Lyu Z
    J Diabetes; 2022 Jan; 14(1):15-25. PubMed ID: 34623029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonalbuminuric Diabetic Kidney Disease and Risk of All-Cause Mortality and Cardiovascular and Kidney Outcomes in Type 2 Diabetes: Findings From the Hong Kong Diabetes Biobank.
    Jin Q; Luk AO; Lau ESH; Tam CHT; Ozaki R; Lim CKP; Wu H; Jiang G; Chow EYK; Ng JK; Kong APS; Fan B; Lee KF; Siu SC; Hui G; Tsang CC; Lau KP; Leung JY; Tsang MW; Kam G; Lau IT; Li JK; Yeung VT; Lau E; Lo S; Fung S; Cheng YL; Chow CC; Huang Y; Lan HY; Szeto CC; So WY; Chan JCN; Ma RCW;
    Am J Kidney Dis; 2022 Aug; 80(2):196-206.e1. PubMed ID: 34999159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes of the tubular markers in type 2 diabetes mellitus with glomerular hyperfiltration.
    Fu WJ; Li BL; Wang SB; Chen ML; Deng RT; Ye CQ; Liu L; Fang AJ; Xiong SL; Wen S; Tang HH; Chen ZX; Huang ZH; Peng LF; Zheng L; Wang Q
    Diabetes Res Clin Pract; 2012 Jan; 95(1):105-9. PubMed ID: 22015481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Risk Factors for Progression of Diabetic and Nondiabetic CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Anderson AH; Xie D; Wang X; Baudier RL; Orlandi P; Appel LJ; Dember LM; He J; Kusek JW; Lash JP; Navaneethan SD; Ojo A; Rahman M; Roy J; Scialla JJ; Sondheimer JH; Steigerwalt SP; Wilson FP; Wolf M; Feldman HI;
    Am J Kidney Dis; 2021 Jan; 77(1):56-73.e1. PubMed ID: 32866540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.